• Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure

    1 month ago - By MedPage Today

    FDA expanded the emergency use authorization for the monoclonal antibody cocktail casirivimab and imdevimab, to include post-exposure prophylaxis among certain people exposed to COVID-19, manufacturer Regeneron announced...
    Read more ...